Feasibility is often considered the process to determine if a clinical site and investigator are a good fit for a clinical trial when in fact, feasibility assessments begin long before site evaluations. With trials becoming more complex, it is vital for sponsors and CRO’s to collaborate to determine the feasibility of the trial itself. Aggressive timelines and tight budgets make trial feasibility relevant in all components of trial design and clinical strategy. Pre award feasibility assessments consider multiple factors to ensure trial success and operational efficiencies. A panel of CATO SMS experts will discuss the role of pre award feasibility assessments and challenges in order to drive clinical strategies, meet the timelines and trial endpoints in a cost efficient manner.
Webinar Key benefits for you:
- Identify key elements in clinical trial feasibility
- Incorporating feasibility assessments into the big picture
- Importance of accurate data and relevant resources
- Discuss the significance of enrollment scenarios
- Pre award feasibility versus site level feasibility
- Recognize challenges in study design and how to overcome them
- What does the future look like in feasibility and clinical strategy
Click button below to register.
Even if you will not be able to attend please register and we will send you a recording of the webinar once it’s available.
About the Presenters
Adam Coleman, MSPAS, PAC
Dr. Coleman has more than 15 years of clinical practice as a Physician Assistant with experience in trauma/emergency medicine, internal medicine and sports medicine. He was a faculty member at Duke University school of Medicine where he ran the Emergency Medicine Program for Medical and PA students. He transitioned to clinical research over 5 years ago working on oncology trials in various consulting roles. From there he started a global site identification and site relations department where he and his team utilized their global feasibility capabilities to develop site and network relationships to enhance clinical trial efficiencies with innovative and strategic ideas. At CATO SMS his responsibilities include professionally disrupting the status quo, conducting clinical trial feasibility reviews, clinical strategy development, clinical and medical consulting for projects and bid defense participation while establishing site and investigator relationships.
Laura DiMichelle, Ph.D.
Senior Director, Clinical Strategy
Clinical Research Manager